Tharimmune Statistics Share Statistics Tharimmune has 4.64M
shares outstanding. The number of shares has increased by 131.62%
in one year.
Shares Outstanding 4.64M Shares Change (YoY) 131.62% Shares Change (QoQ) 21.7% Owned by Institutions (%) n/a Shares Floating 1.82M Failed to Deliver (FTD) Shares 1,097 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 61.82K, so 1.17% of the outstanding
shares have been sold short.
Short Interest 61.82K Short % of Shares Out 1.17% Short % of Float 1.17% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.22 and the forward
PE ratio is -3.72.
Tharimmune's PEG ratio is
0.
PE Ratio -0.22 Forward PE -3.72 PS Ratio 0 Forward PS n/a PB Ratio 2.01 P/FCF Ratio -0.24 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tharimmune.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.54,
with a Debt / Equity ratio of 0.
Current Ratio 1.54 Quick Ratio 1.54 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -908.64
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-6.1M Employee Count 2 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 3.39% in the
last 52 weeks. The beta is 1.59, so Tharimmune's
price volatility has been higher than the market average.
Beta 1.59 52-Week Price Change 3.39% 50-Day Moving Average 2.46 200-Day Moving Average 1.89 Relative Strength Index (RSI) 47.39 Average Volume (20 Days) 10,098,669
Income Statement
Revenue n/a Gross Profit n/a Operating Income -12.43M Net Income -12.2M EBITDA -12.43M EBIT -12.21M Earnings Per Share (EPS) -9.41
Full Income Statement Balance Sheet The company has 3.56M in cash and 0 in
debt, giving a net cash position of 3.56M.
Cash & Cash Equivalents 3.56M Total Debt n/a Net Cash n/a Retained Earnings -36.9M Total Assets 2.53M Working Capital 367.36K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.9M
and capital expenditures 0, giving a free cash flow of -10.9M.
Operating Cash Flow -10.9M Capital Expenditures n/a Free Cash Flow -10.9M FCF Per Share -8.41
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields THAR does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for THAR is $17,
which is 457.4% higher than the current price. The consensus rating is "Buy".
Price Target $17 Price Target Difference 457.4% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 28, 2024. It was a
backward
split with a ratio of 1:15.
Last Split Date May 28, 2024 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -36.83 Piotroski F-Score 1
